Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | SVP, Worldwide Sales | April 24, 2017 | April 25, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date April 24, 2017 · Filed April 25, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,928 |
Reported balance
After 2017-04-24 transaction · row 1
1 source rowRow 1 · 2017-04-24 · Grant · Acquired 13,928 · Balance 13,928 F1: One-fourth of the total number of deferred stock units shall vest and be delivered on April 30th of each year commencing on April 30, 2018. |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.70 · Expires 2024-04-24 | Direct | 35,056 |
Reported balance
After 2017-04-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-04-24 · Grant · Acquired 35,056 · Balance 35,056 F2: One-fourth of the total number of shares subject to the option shall vest and become exercisable on the 12-month anniversary of the April 24, 2017 grant date, and 1/16th of the total number of shares subject to the option shall vest and become exercisable each quarter thereafter until fully vested on April 24, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth of the total number of deferred stock units shall vest and be delivered on April 30th of each year commencing on April 30, 2018.
F2: One-fourth of the total number of shares subject to the option shall vest and become exercisable on the 12-month anniversary of the April 24, 2017 grant date, and 1/16th of the total number of shares subject to the option shall vest and become exercisable each quarter thereafter until fully vested on April 24, 2021.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
XILINX INC
Report date February 14, 2022 · Filed February 16, 2022
Section 16 reporting ended · disclosed 2022-02-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 1
1 source rowRow 1 · 2022-02-14 · Disposition to issuer · Disposed 294 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (Merger Agreement) between Issuer and Advanced Micro Devices, Inc. (AMD), dated as of October 26, 2020, each share of Issuer common stock was converted into the right to receive 1.7234 shares of AMD common stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2022-04-10 | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-14 · Disposition to issuer · Disposed 6,246 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2023-07-10 | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-14 · Disposition to issuer · Disposed 1,900 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2022-07-10 | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-14 · Disposition to issuer · Disposed 950 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F3: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 3 substantially equal installments on each of the first 3 anniversaries of the award grant date through the Expiration Date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2024-07-10 | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-14 · Disposition to issuer · Disposed 20,400 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2023-07-10 | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-02-14 · Disposition to issuer · Disposed 5,554 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F3: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 3 substantially equal installments on each of the first 3 anniversaries of the award grant date through the Expiration Date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2025-07-12 | Direct | 0 |
Reported balance
After 2022-02-14 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-02-14 · Disposition to issuer · Disposed 21,200 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (Merger Agreement) between Issuer and Advanced Micro Devices, Inc. (AMD), dated as of October 26, 2020, each share of Issuer common stock was converted into the right to receive 1.7234 shares of AMD common stock.
F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions.
F3: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 3 substantially equal installments on each of the first 3 anniversaries of the award grant date through the Expiration Date.
F4: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerRestricted Stock Unit · Derivative | 21,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · derivative · entry 7 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,200 shares Expires 2025-07-12 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4 · derivative.exercise_date: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerRestricted Stock Unit · Derivative | 5,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · derivative · entry 6 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,554 shares Expires 2023-07-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F3 · derivative.exercise_date: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 3 substantially equal installments on each of the first 3 anniversaries of the award grant date through the Expiration Date. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerRestricted Stock Unit · Derivative | 20,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · derivative · entry 5 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,400 shares Expires 2024-07-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4 · derivative.exercise_date: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerRestricted Stock Unit · Derivative | 950 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · derivative · entry 4 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 950 shares Expires 2022-07-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F3 · derivative.exercise_date: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 3 substantially equal installments on each of the first 3 anniversaries of the award grant date through the Expiration Date. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerRestricted Stock Unit · Derivative | 1,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · derivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,900 shares Expires 2023-07-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4 · derivative.exercise_date: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerRestricted Stock Unit · Derivative | 6,246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · derivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,246 shares Expires 2022-04-10 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F2 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock upon vesting of the unit, which, pursuant to the Merger Agreement, was converted into units representing the right to receive 1.7234 shares of AMD common stock subject to the same vesting and other terms and conditions. F4 · derivative.exercise_date: Date Exercisable represents the initial vesting date of the units which, subject to continued employment through the applicable vesting date, vest in 4 substantially equal installments on each of the first 4 anniversaries of the award grant date through the Expiration Date. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 16:07 UTC | XILINX INC XLNX · Entity 130374 | Disposition to issuerCommon Stock | 294 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-004590 · form4.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (Merger Agreement) between Issuer and Advanced Micro Devices, Inc. (AMD), dated as of October 26, 2020, each share of Issuer common stock was converted into the right to receive 1.7234 shares of AMD common stock. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 14:55 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 589 | $211.00 | $124,276.35 |
DisclosureSEC source: 0000743988-22-000011 · primary_doc.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294 F1 · price: All shares sold at one price. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 3,554 | $149.42 | $531,047.21 |
DisclosureSEC source: 0001246360-21-000869 · form.xml · nonDerivative · entry 4 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589 F1 · price: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F5 · price: Price represents weighted average for sales reported. The range of prices for the sales reported is $148.7000 - $149.6900 Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 1,100 | $151.92 | $167,114.97 |
DisclosureSEC source: 0001246360-21-000869 · form.xml · nonDerivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 F1 · price: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F4 · price: Price represents weighted average for sales reported. The range of prices for the sales reported is $151.7100 - $152.1100 Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 2,821 | $151.15 | $426,390.48 |
DisclosureSEC source: 0001246360-21-000869 · form.xml · nonDerivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,243 F1 · price: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: Price represents weighted average for sales reported. The range of prices for the sales reported is $150.7400 - $151.6400 Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 21:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 7,314 | $149.90 | $1,096,388.35 |
DisclosureSEC source: 0001246360-21-000869 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,064 F1 · price: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: Price represents weighted average for sales reported. The range of prices for the sales reported is $149.7000 - $150.6600 Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 21,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · derivative · entry 10 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,200 Underlying: XLNX COMMON STOCK · 21,200 shares Expires 2025-07-12 F4 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F3 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 6,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · derivative · entry 9 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,400 Underlying: XLNX COMMON STOCK · 6,800 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F3 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 2,776 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · derivative · entry 8 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,554 Underlying: XLNX COMMON STOCK · 2,776 shares Expires 2023-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · derivative · entry 7 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Underlying: XLNX COMMON STOCK · 950 shares Expires 2023-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F3 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · derivative · entry 6 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950 Underlying: XLNX COMMON STOCK · 950 shares Expires 2022-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 5,663 | $135.59 | $767,846.17 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · nonDerivative · entry 5 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,378 Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · nonDerivative · entry 4 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · nonDerivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 6,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · nonDerivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| July 10, 2021 Filed Jul 13, 2021 18:21 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 2,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000837 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:21 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 8,330 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000732 · form.xml · derivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,330 Underlying: XLNX COMMON STOCK · 8,330 shares Expires 2023-07-10 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 10, 2021 Filed Apr 13, 2021 20:42 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 6,245 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000659 · form.xml · derivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Underlying: XLNX COMMON STOCK · 6,245 shares Expires 2022-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 10, 2021 Filed Apr 13, 2021 20:42 UTC | XILINX INC XLNX · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 2,175 | $129.72 | $282,141.00 |
DisclosureSEC source: 0001246360-21-000659 · form.xml · nonDerivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,565 Read SEC document |
| April 10, 2021 Filed Apr 13, 2021 20:42 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 6,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000659 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 13:14 UTC | XILINX INC xlnx · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001466 · primary_doc.xml · derivative · entry 6 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Underlying: XLNX COMMON STOCK · 950 shares Expires 2022-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 13:14 UTC | XILINX INC xlnx · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 950 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001466 · primary_doc.xml · derivative · entry 5 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,850 Underlying: XLNX COMMON STOCK · 950 shares Expires 2023-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F3 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 13:14 UTC | XILINX INC xlnx · Entity 130374 | GrantRestricted Stock Unit · Derivative | 27,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001466 · primary_doc.xml · derivative · entry 4 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,200 Underlying: XLNX COMMON STOCK · 27,200 shares Expires 2024-07-10 F3 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 13:14 UTC | XILINX INC xlnx · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 658 | $99.14 | $65,234.12 |
DisclosureSEC source: 0001246360-20-001466 · primary_doc.xml · nonDerivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,201 Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 13:14 UTC | XILINX INC xlnx · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001466 · primary_doc.xml · nonDerivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 13:14 UTC | XILINX INC xlnx · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 950 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001466 · primary_doc.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| May 12, 2020 Filed May 13, 2020 19:42 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 2,850 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001194 · form.xml · derivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,850 Underlying: XLNX COMMON STOCK · 2,850 shares Expires 2022-07-10 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 17:35 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 2,236 | $84.57 | $189,098.52 |
DisclosureSEC source: 0001246360-20-001051 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,959 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · price: All shares sold at one price. Read SEC document |
| April 10, 2020 Filed Apr 13, 2020 21:49 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 6,245 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001047 · form.xml · derivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,491 Underlying: XLNX COMMON STOCK · 6,245 shares Expires 2022-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 10, 2020 Filed Apr 13, 2020 21:49 UTC | XILINX INC XLNX · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 2,179 | $83.11 | $181,096.69 |
DisclosureSEC source: 0001246360-20-001047 · form.xml · nonDerivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,195 Read SEC document |
| April 10, 2020 Filed Apr 13, 2020 21:49 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 6,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-20-001047 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. Read SEC document |
| July 10, 2019 Filed Jul 10, 2019 21:49 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 3,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001759 · form.xml · derivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 Underlying: XLNX COMMON STOCK · 3,800 shares Expires 2023-07-10 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 20:49 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 2,241 | $133.10 | $298,277.10 |
DisclosureSEC source: 0001246360-19-001233 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,834 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: All shares sold at one price Read SEC document |
| April 10, 2019 Filed Apr 11, 2019 18:56 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 6,245 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001225 · form.xml · derivative · entry 3 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,736 Underlying: XLNX COMMON STOCK · 6,245 shares Expires 2022-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 10, 2019 Filed Apr 11, 2019 18:56 UTC | XILINX INC XLNX · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 2,170 | $131.59 | $285,550.30 |
DisclosureSEC source: 0001246360-19-001225 · form.xml · nonDerivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,075 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. Read SEC document |
| April 10, 2019 Filed Apr 11, 2019 18:56 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 6,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001225 · form.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 20:14 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 24,981 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-18-001287 · form.xml · derivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,981 Underlying: XLNX COMMON STOCK · 24,981 shares Expires 2022-04-10 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in equal installments and be settled on each of the first four anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantEmployee Stock Options (Right to Buy) · Derivative | 35,056 | $0.00 Strike: $51.70 | $0.00 |
DisclosureSEC source: 0001209191-17-028181 · doc4.xml · derivative · entry 2 Wadlington Mark · CIK 0001519702 · SVP, Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,056 Underlying: Common Stock · 35,056 shares Expires 2024-04-24 F2 · derivative.exercise_date: One-fourth of the total number of shares subject to the option shall vest and become exercisable on the 12-month anniversary of the April 24, 2017 grant date, and 1/16th of the total number of shares subject to the option shall vest and become exercisable each quarter thereafter until fully vested on April 24, 2021. Read SEC document |
| April 24, 2017 Filed Apr 25, 2017 23:10 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 13,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-028181 · doc4.xml · nonDerivative · entry 1 Wadlington Mark · CIK 0001519702 · SVP, Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,928 F1 · shares: One-fourth of the total number of deferred stock units shall vest and be delivered on April 30th of each year commencing on April 30, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.